PGC-1α驱动小细胞神经内分泌癌症向ASCL1表达亚型的进展,其线粒体容量增加
bioRxiv : the preprint server for biology
|April 22, 2024
概括
代谢重编程驱动小细胞神经内分泌 (SCN) 癌症的进展和亚型的确定. 由PGC-1α诱导的线粒体代谢是关键的驱动因素,为这些耐治疗癌症揭示了新的治疗点.
科学领域:
- 在瘤学瘤学.
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- 腺癌可以转化为致命的,耐治疗的小细胞神经内分泌 (SCN) 癌症,代谢概况不明.
- 代谢对SCNC亚型的决定的影响尚不清楚.
- 小细胞神经内分泌癌 (SCNCs) 由于治疗耐药性,存在重大治疗挑战.
研究的目的:
- 调查新陈代谢在驱动SCNC亚型确定中的作用.
- 确定参与SCNC进展的关键代谢调节者.
- 探索在SCNCs治疗向的潜在代谢漏洞.
主要方法:
- 数以千计的患者瘤的生物信息分析,以确定代谢变化.
- 使用患者衍生的前列腺SCNC转换系统.
- 采用细胞系增殖试验和瘤形成研究.
- 使用小动物正子发射断层扫描对线粒体成像进行验证的发现.
主要成果:
- 增强的PGC-1α,一种氧化酸化调节剂 (OXPHOS),在各种SCNC中被确定,与神经内分泌分化有关.
- 表达ASCL1的亚型显示高的PGC-1α和增加的OXPHOS.
- 抑制PGC-1α和OXPHOS可以减少SCNC的扩散和瘤的形成.
- 增强PGC-1α和OXPHOS增加了SCNC瘤的形成,并促进了ASCL1血统.
结论:
- 代谢重编程直接影响SCNCs中的癌症表型.
- 由PGC-1α诱导的线粒体新陈代谢驱动SCNC的进展和谱系的确定.
- 鉴定了来自多种组织的SCNCs的共同代谢漏洞,这表明了泛SCN癌症治疗策略.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
10:26Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
1.9K
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Electron Transport Chain: Complex I and II
13.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.1K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K
